Concepedia

Roland Tschismarov

RT

Statistics

Publications

14

Citations

905

H-Index

14

Active since

2010

Affiliations

Max Perutz Labs(Current)

Medical University of Vienna

Themis Bioscience (Austria)

Vienna Biocenter

University of Vienna

Roland Tschismarov is an author at Max Perutz Labs specializing in immunology, life sciences, and vaccinology.

ORCID

Publications per year

2010–2023

14

Publications

14

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Emil C. Reisinger, Roland Tschismarov, Eckhard Beubler et al. · The Lancet · 2018 · 180 citations

, , +14

Conditional Deletion of Histone Deacetylase 1 in T Cells Leads to Enhanced Airway Inflammation and Increased Th2 Cytokine Production

Reinhard Grausenburger, Ivan Bilić, Nicole Boucheron et al. · The Journal of Immunology · 2010 · 132 citations · Full text

, , +16

Intracellular bacteria engage a STING–TBK1–MVB12b pathway to enable paracrine cGAS–STING signalling

Ramya Nandakumar, Roland Tschismarov, Felix Meissner et al. · Nature Microbiology · 2019 · 128 citations · Full text

, , +14

The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunity

Daniel Szappanos, Roland Tschismarov, Thomas Perlot et al. · PLoS Pathogens · 2018 · 87 citations · Full text

, , +17

CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2

Nicole Boucheron, Roland Tschismarov, Lisa Göschl et al. · Nature Immunology · 2014 · 82 citations

, , +12

1–5 of 14